812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 150; no. 4; p. S1267
Main Authors Vermeire, Severine, Schreiber, Stefan, Petryka, Robert, Kuehbacher, Tanja, Hebuterne, Xavier, Roblin, Xavier, Klopocka, Maria, Goldis, Adrian, Wisniewska-Jarosinska, Maria A., Baranovsky, Andrei, Sike, Robert, Tasset, Chantal T., Van der Aa, Annegret, Harrison, Pille
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.04.2016
Subjects
Gastroenterology and Hepatology
Online AccessGet full text
ISSN0016-5085
1528-0012
DOI10.1016/S0016-5085(16)34280-9

Cover

More Information
ISSN:0016-5085
1528-0012
DOI:10.1016/S0016-5085(16)34280-9